Centogene

Germany
Rostock, Mecklenburg-Vorpommern, Germany, 18055

Company profile

Centogene company profile

CENTOGENE is one of the largest genetic biotech companies worldwide, the European market leader, and one of the global leaders in genetic diagnostic analyses of rare inherited diseases. Transforming global genetic data into medical decisions, that are focused on creating broarder awareness for patients of all ethnicities around the world. CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients. With headquarters in Rostock, Germany and further operations in Berlin, Germany as well as Cambridge, Massachusetts, USA, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families. CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$50,000+
Founded
2006-01-01, Year

Headquarters

Postal code
18055
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$149.9M
Last funding
Post IPO Debt / $30M / 2023-06-28
Last equity funding
Post IPO Equity / $16.9M
Investors
6
Lead investors
5
Founders
1
Articles
101
Exited on
2019-11-07

Founders and investors

Founders

Arndt Rolfs

Lead investors

CareventuresDPE Deutsche Private EquityLiferaOxford Finance LLCTVM Capital Life Science

Investors

CareventuresCIC CapitalDPE Deutsche Private EquityOxford Finance LLCTVM Capital Life Science